Expression of the murine leukemia virus poi gene occurs by translational readthrough of an in-frame UAG codon between the gag and poi coding regions. In a previous study, we mutated the UAG codon to UAA or UGA and demonstrated that both of these termination codons could be suppressed in reticulocyte lysates and in infected cells with the same efficiency as UAG. We now report the identity of the amino acids inserted in vitro in response to UAA and UGA in fusion products containing the gag-pol junction region. The results show that UAA, like UAG, directs the incorporation of glutamine, whereas UGA directs the incorporation of three amino acids, arginine, cysteine, and tryptophan. To our knowledge, this is the first report indicating misreading of UAA as glutamine and UGA as arginine and cysteine in higher eukaryotes. Interestingly, although our protein synthesis system presumably contains other known UAG and UGA suppressors, these tRNAs did not suppress the termination codons in our experiments. Thus, it seems possible that the sequence surrounding the gag-pol junction not only promotes suppression but also helps determine which tRNAs function in suppression.
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Readthrough suppression of termination codons is a mechanism of translational regulation that is used by a number of viruses infecting higher eukaryotes. The analysis of this phenomenon thus provides new information on the functional capabilities of the translational apparatus of these organisms. We have been investigating suppression in the murine leukemia virus (MuLV) system (1, 2). MuLV, like other mammalian type C retroviruses, regulates pol gene expression by translational readthrough ofan in-frame UAG codon between the gag and pol coding regions (3) (4) (5) . Suppression of this termination codon occurs with a frequency of about 5% (3) (4) (5) and is mediated by insertion of a glutamine residue at the position corresponding to the UAG (6) . The readthrough product is a 200-kDa gag-pol fusion protein, which is cleaved at a late stage in virus assembly to give rise to protease, reverse transcriptase, and integrase (3).
To determine whether the signals that govern readthrough are unique for UAG, we used oligonucleotide-directed mutagenesis to change the UAG at the Moloney (Mo)-MuLV gag-pol junction to UAA or UGA (2) . Interestingly, we found that these termination codons could be efficiently suppressed both in reticulocyte lysates and in infected cells (2) . These results demonstrated that the suppression signals are not specific for UAG and that mammalian cells and cell extracts contain tRNAs capable of suppressing UGA and UAA codons which appear in a retroviral context. Similar findings have been reported by other investigators working with tobacco mosaic virus (TMV) (7), Sindbis virus (8) , and MuLV (9) .
In the present study we have identified the amino acids inserted in response to UAA and UGA by using an in vitro MuLV suppression system (1). We find that UAA, like UAG, directs the incorporation of glutamine into protein, whereas UGA directs the incorporation ofthree amino acids, arginine, cysteine, and tryptophan. To our knowledge, misreading of UAA as glutamine and UGA as arginine and cysteine has not previously been reported in higher eukaryotes. (10) , and a 3' HindIII site was inserted between the SP6 promoter of pGEM4Z (Promega) and a portion ofthe Staphylococcus aureus protein A gene (11) (Fig. 1) Protein Synthesis and Analysis. The plasmids were digested with Pst I (which cleaves in the polylinker region of pRIT2T upstream of the Sal I site) and were transcribed with SP6 RNA polymerase (1) . The resulting mRNAs were translated in rabbit reticulocyte lysates supplemented with calf liver tRNA (Promega) at 50 jig/ml and with the indicated radiolabeled amino acids (3H, 0.5 mCi/ml; 35S, 0.85 mCi/ml), as described (1) . Incubation was at 30'C for 30 min unless indicated otherwise. The protein products were isolated by binding to rabbit IgG-Sepharose (Pharmacia) (13) tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. cation on IgG-Sepharose and gel electrophoresis, the resulting protein band was excised from the gel, eluted with water, and processed for amino acid sequence analysis by Edman degradation in a Beckman 890C automated spinning-cup sequenator (14) .
RESULTS
Translation of SP6-Pronoted Transcripts Containing Termination or Sense Codons. To determine the identity ofamino acids inserted in response to termination or sense codons, we used an approach similar to the one described by Jacks et al. (15) in their analysis of ribosomal frameshifting in human immunodeficiency virus. We designed mini-construct plasmids with an SP6 promoter followed by a 15-nt leader sequence (with an AUG codon) linked to 6 nt from the 3' end of gag, a termination or sense codon (UAG, UAA, UGA, or the glutamine codeword CAG), 57 nt from the 5' end of pol, and the sequence encoding the binding domain of protein A (Fig. 1 ). SP6 transcripts of each plasmid were generated and translated in a rabbit reticulocyte lysate (1) . Protein A fusion products ("suppressed products") were purified by binding to IgG-Sepharose and analyzed in an SDS/polyacrylamide gel ( Fig. 2) . Products in which suppression does not occur ("terminated products") are only seven residues long and were not detected; thus, the level of suppression is not directly measured in these experiments.
As illustrated in Fig. 2 indicated by a boxed X. To obtain sufficient material for analysis, large-scale reactions containing 1 labeled amino acid and 19 unlabeled amino acids in excess were performed. The protein products were purified and sequenced as described in Materials and Methods.
Transcripts containing UAG, UAA, or CAG codons at the gag-pol junction were translated in reactions with [3H1-glutamine (Fig. 4A) . The protein A fusion product should have glutamine at positions 11 and 13 (Fig. 3) , and inspection of Fig. 4A shows that in each case, glutamine was detected in the 11th and 13th cycles of the Edman degradation. Since CAG is a glutamine codeword, it is not surprising that glutamine was inserted at position 8 in the CAG reaction. Glutamine was also incorporated at position 8 in response to the UAG-containing mRNA; this result indicates that the in vitro translation reaction mimics suppression in vivo, where it is known that the UAG codon at the MuLV gag-pol junction is read as glutamine (6) . In addition, the data of Fig.  4A show that glutamine was inserted at position 8 in response to UAA, demonstrating that a glutamine isoacceptor can serve as a UAA suppressor in mammalian cells. Comparison of the UAG and UAA results with the data obtained for the CAG product (which can be viewed as a "standard" for glutamine incorporation) shows that the relative amounts of glutamine inserted at positions 8, 11, and 13 were the same in all three fusion proteins. This finding provides strong evidence that UAG and UAA, like CAG, are translated predominantly, if not exclusively, as glutamine at position 8. The data of Fig. 4B represent control experiments which show that [3H]leucine is found only at position 4 in the UAG, UAA, and CAG products, as predicted from the amino acid sequence (Fig. 3) .
To determine which amino acid is inserted in response to UGA, we tested all amino acids whose codons differ from UGA by a single nucleotide and/or which have G at the second position: arginine, cysteine, glycine, leucine, serine, and tryptophan. Surprisingly, not one, but three amino acids-arginine, cysteine, and tryptophan-were found at position 8 (Fig. 5) . Arginine, as anticipated (Fig. 3) , was also found at positions 2 and 20. The frequency of insertion of arginine into position 8 was quite low, presumably reflecting competition between the labeled arginine and unlabeled tryptophan and cysteine, which were also present in the 1 position 3, glycine at positions 5, 9, 10, and 12, and leucine at position 4, as predicted from the sequence (Fig. 3) ; however, none of these amino acids was detected at position 8 (data not shown).
DISCUSSION
In the present study, we have used mini-constructs to identify the amino acids inserted in vitro in response to UAA and UGA termination codons placed at the MuLV gag-poljunction. We find that UAA, like UAG, directs the incorporation ofglutamine, whereas three amino acids-arginine, cysteine, and tryptophan-are incorporated in response to UGA.
The observation that glutamine is inserted into the protein A fusion protein in response to UAG (Fig. 4A) emphasizes the parallel between suppression in vitro and in vivo (1, 2, 6) and supports the use of the in vitro system in this study. It is of particular interest that leucine is not incorporated at the UAG position (Fig. 4B) , since calf liver tRNA, the major source of tRNA in the supplemented reticulocyte lysate (1), is known to contain two leucine amber suppressor tRNAs (16) . This lack of leucine incorporation highlights the specificity of the MuLV suppression system. While Kuchino et al. (17) reported that infection with Mo-MuLV alters the cellular profile of glutamine tRNAs, we found no difference between tRNAs of infected and uninfected cells (1) . In contrast to the proposal of Kuchino et al. (17) , our results (1, 2), as well as those of Panganiban (18), strongly suggested that suppression is mediated by a cellular tRNA that is neither altered nor induced as a result of virus infection.
The identity of the mouse cell glutamine isoacceptor that suppresses UAG at the MuLV gag-pol junction is not known. Kuchino et al. (17) isolated a minor glutamine tRNA that was reported to suppress the UAG codon of TMV RNA in a rabbit reticulocyte lysate. It is not clear that this tRNA can also suppress the MuLV UAG codon as suggested (17) , however, since the MuLV and TMV systems are not entirely equivalent. Thus, in contrast to the situation with MuLV (Fig. 4) , the tRNA specificity for in vitro suppression of the TMV UAG codon is less stringent and several tRNAs exhibit suppressor activity, including glutamine (17) and leucine (16) , as well as the hypomodified tyrosine tRNA that is the TMV suppressor in vivo (19) .
To date a mammalian UAA suppressor has not been isolated and indeed, UAA was once considered to be an absolute termination codon in mammalian cells (20, 21) . Recently, it has been possible to demonstrate readthrough suppression of UAA in viral systems where the natural UAG codon [MuLV (2, 9) and TMV (7) (Fig. 2 and ref. 2) .
The finding that UGA is decoded as three different amino acids (Fig. 5) is unique. Moreover, to our knowledge, misreading of UGA as cysteine and arginine has never been described in mammalian cells. Interestingly, the present results are in accord with early codon-recognition studies from Nirenberg's laboratory which showed that fractionated (27) and unfractionated (28) guinea pig liver tRNA acylated with cysteine binds' to ribosomes in response to UGA.
Subsequently., Hatfield (29) found that fractionated arginine, cysteine, and tryptophan tRNAs from calf liver show a weak response to UGA in the ribosomal binding assay. (20) proposed that mammalian tryptophan tRNA can function as a UGA suppressor. In bacteria, wild-type tryptophan tRNA and a mutant tryptophan suppressor tRNA with a G -A change at position 24 (30) decode the UGG' tryptophan codon and UGA in vitro (31) and in vivo (32) . The suppressor tRNA also decodes the UGU cysteine codon with low efficiency in vitro (33) . Since mammalian tryptophan tRNA, like its bacterial counterpart (30) , is expected to have a CCA anticodon, interaction with UGA may require C-A mispairing at the third position of the codon. Similarly, insertion of cysteine (UGU and UGC codons) in response to UGA would be expected to involve mispairing at the third position of the codon. Although arginine has six codons and several isoacceptors (29) , the most likely candidate for suppressor activity would appear to be a CGA-decoding tRNA, which could suppress UGA by G-U mispairing at the first position of the codon, in analogy to the interactions of glutamine tRNAs with UAA and UAG in yeast (24) (25) (26) , and possibly in MuLV. It is also possible that 'as yet unidentified specialized UGA suppressor tRNA(s) are involved in the readthrough suppression that is observed at the gag-pol junction.
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